Movement DisordersNeurosciencePeer-reviewed journal article
Amantadine modulates action-specific neural ensembles in hypokinetic and hyperkinetic conditions
Gaurav ChattreeiD, Radosław ChrapkiewicziD, Yanping ZhangiD, Jane LiiD, Fatih DinçiD, Mark J. SchnitzeriD
Abstract
BackgroundIn the classical model of basal ganglia circuitry, striatal spiny projection neurons of the direct and indirect pathways (dSPNs, iSPNs) promote and suppress movement, respectively, and exhibit unbalanced activity levels during hypokinetic or hyperkinetic conditions. Most therapies for these conditions are thought to work by rebalancing the relative activity of dSPNs and iSPNs towards normal levels. However, the mechanism of amantadine, which uniquely improves both hypokinetic and hyperkinetic conditions, is poorly understood. ObjectiveTo determine whether amantadine restores motor function by normalizing the balance of dSPN and iSPN activity or through a distinct mechanism. MethodsWe used dual-color two-photon Ca2+ imaging in the 6-OHDA mouse model of Parkinsons disease to concurrently monitor dSPN and iSPN dynamics across healthy, hypokinetic (parkinsonian), and hyperkinetic (dyskinetic) conditions. ResultsWe evaluated both dSPN/iSPN activity balance and action-specific neural ensemble activity in the dorsolateral striatum. In hypokinetic conditions, L-DOPA rescued the dSPN/iSPN imbalance but failed to restore the disrupted activity of the locomotion-specific ensemble. Conversely, amantadine improved locomotion-specific ensemble activity without normalizing the dSPN/iSPN imbalance. In hyperkinetic conditions, forelimb dyskinesias were characterized by neural activity patterns distinct from those encoding locomotion. Amantadine selectively suppressed the resting activity of forelimb dyskinesia ensembles without affecting locomotion-coding ensembles or restoring pathway balance. ConclusionsL-DOPA and amantadine may act through distinct mechanisms, with L-DOPA normalizing pathway balance and amantadine modulating action-specific neural ensembles. These findings support the importance of action-coding disruptions during hypokinetic and hyperkinetic conditions and suggest that correcting them can restore motor function.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 45%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Abnormal hyperactivity of specific striatal ensembles encodes distinct dyskinetic behaviors revealed by high-resolution clustering
Cristina Alcacer, Andreas Klaus, … Rui M. Costa·Cell ReportsPeer-reviewed·Jul 1, 2025
- Dopamine differentially modulates the size of projection neuron ensembles in the intact and dopamine-depleted striatum
Marta Maltese, Jeffrey R. March, … Nicolas X. Tritsch·eLifePeer-reviewed·May 13, 2021
- Selective inhibition of goal-directed actions in the mesencephalic locomotor region
Nadine K. Gut, Duygu Yilmaz, … Juan Mena‐Segovia·bioRxiv·Jan 18, 2022
- Transient dopamine neuron activity precedes and encodes the vigor of contralateral movements
Marcelo Mendonça, Joaquim Alves da Silva, … Rui M. Costa·Current BiologyPeer-reviewed·Feb 19, 2024
- Striatal Direct Pathway Targets Npas1+ Pallidal Neurons
Qiaoling Cui, Xixun Du, … C. Savio Chan·Journal of NeurosciencePeer-reviewed·Mar 17, 2021
- Dopamine serves as an independent gain regulator to shape striatal control of movement
Jingheng Zhou, Riley M Harper, … Julieta E. Lischinsky·bioRxiv·Aug 20, 2026